The reduction of 9.1% in death from CV, MI, or stroke was for the 2.5mg dose not both doses. The combined reduction for both doses was 8.9%.
One more point that was mentioned in theheart.org article is the number-needed-to-treat-to-benefit (NNT) - 56 (one death prevented for every 56 patients treated for two years), which is quite good.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.